Marshall Wace’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $518K | Buy |
13,100
+3,998
| +44% | +$158K | ﹤0.01% | 2000 |
|
|
2025
Q1 | $275K | Sell |
9,102
-803,204
| -99% | -$24.2M | ﹤0.01% | 2178 |
|
|
2024
Q4 | $28.4M | Sell |
812,306
-1,108,158
| -58% | -$38.7M | 0.03% | 406 |
|
|
2024
Q3 | $76.9M | Buy |
1,920,464
+1,747,265
| +1,009% | +$70M | 0.09% | 181 |
|
|
2024
Q2 | $8.25M | Buy |
173,199
+157,756
| +1,022% | +$7.52M | 0.01% | 745 |
|
|
2024
Q1 | $669K | Sell |
15,443
-118,106
| -88% | -$5.12M | ﹤0.01% | 1592 |
|
|
2023
Q4 | $6.76M | Buy |
133,549
+65,422
| +96% | +$3.31M | 0.01% | 674 |
|
|
2023
Q3 | $3.09M | Sell |
68,127
-936
| -1% | -$42.5K | 0.01% | 917 |
|
|
2023
Q2 | $2.83M | Buy |
+69,063
| New | +$2.83M | 0.01% | 1034 |
|
|
2021
Q3 | – | Sell |
-176,820
| Closed | -$7.05M | – | 2603 |
|
|
2021
Q2 | $7.05M | Buy |
+176,820
| New | +$7.05M | 0.03% | 582 |
|
|
2021
Q1 | – | Sell |
-111,269
| Closed | -$6.29M | – | 2306 |
|
|
2020
Q4 | $6.29M | Buy |
111,269
+54,407
| +96% | +$3.08M | 0.03% | 456 |
|
|
2020
Q3 | $2.7M | Buy |
+56,862
| New | +$2.7M | 0.02% | 688 |
|
|
2020
Q1 | – | Sell |
-1,016
| Closed | -$61K | – | 1809 |
|
|
2019
Q4 | $61K | Buy |
1,016
+455
| +81% | +$27.3K | ﹤0.01% | 1473 |
|
|
2019
Q3 | $34K | Buy |
+561
| New | +$34K | ﹤0.01% | 1499 |
|
|
2019
Q2 | – | Sell |
-45
| Closed | -$4K | – | 1533 |
|
|
2019
Q1 | $4K | Buy |
+45
| New | +$4K | ﹤0.01% | 1640 |
|
|
2018
Q4 | – | Sell |
-8,939
| Closed | -$461K | – | 1684 |
|
|
2018
Q3 | $461K | Buy |
+8,939
| New | +$461K | ﹤0.01% | 943 |
|
|
2016
Q1 | – | Sell |
-128,328
| Closed | -$7.95M | – | 1101 |
|
|
2015
Q4 | $7.95M | Sell |
128,328
-2,842
| -2% | -$176K | 0.07% | 272 |
|
|
2015
Q3 | $5.3M | Sell |
131,170
-18,115
| -12% | -$732K | 0.07% | 283 |
|
|
2015
Q2 | $8.59M | Buy |
+149,285
| New | +$8.59M | 0.11% | 201 |
|